Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Structure-based peptide inhibitors of P53 aggregation as a new approach to cancer therapeutics

Structure-based peptide inhibitors of P53 aggregation as a new approach to cancer therapeutics

US Patent 9873718 · Granted Jan 23, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Resolution enhancer for a surgical microscope2025
Coherent detection-based high-speed chaotic secure transmission method2024
Method of constructing indoor two-dimensional semantic map with wall corner as c2024
Single nucleotide polymorphism marker related to Chinese horse short stature tra2023
Method, apparatus and system for transmitting data2022
Structure-based peptide inhibitors of α-synuclein aggregation2022
Structure-based peptide inhibitors of α-synuclein aggregation2022
Inhibition of the aggregation of transthyretin by specific binding of peptides t2021
Structure-based peptide inhibitors that target the Tau VQIINK fibrillization seg2021
Method and apparatus for measuring oil content of tight reservoir based on nucle2021
Structure-based peptide inhibitors of alpha-synuclein aggregation2020
Structure-based peptide inhibitors of alpha-synuclein aggregation2020